Adverse effects of antituberculosis drugs.
D000743:Anemia, Hemolytic / Q000139:chemically induced; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D004977:Ethambutol / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D009902:Optic Neuritis / Q000139:chemically induced; D010383:Pellagra / Q000139:chemically induced; D011718:Pyrazinamide / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced; D000159:Vestibulocochlear Nerve / Q000187:drug effects
D000995:Antitubercular Agents; D004338:Drug Combinations; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin